The strategy involves investing in companies with innovative products and services which give them an edge in the long term growth trajectory. This would be a more sector focused investment with primary focus on the following sectors -pharmaceutical, healthcare, animal health, seeds, agrochemicals and specialty chemicals. It may also include certain other niche businesses which have a technology or product/service edge. Under this investment strategy there shall be no market cap preferences. The strategy will invest minimum 70% of the portfolio investment in these companies. This would categorise as a more aggressive portfolio.